|
Originally published In Press as doi:10.1074/jbc.M001008200 on July 13, 2000
J. Biol. Chem., Vol. 275, Issue 43, 33574-33584, October 27, 2000
Temperature-dependent Arrest of Neutrophil
Apoptosis
FAILURE OF Bax INSERTION INTO MITOCHONDRIA AT 15 °C
PREVENTS THE RELEASE OF CYTOCHROME c*
James G.
Pryde ,
Annemieke
Walker§,
Adriano G.
Rossi,
Sharon
Hannah, and
Christopher
Haslett
From the Rayne Laboratory, University of Edinburgh Medical
School, Teviot Place, Edinburgh EH8 9AG, United Kingdom
Received for publication, February 8, 2000, and in revised form, July 12, 2000
 |
ABSTRACT |
Apoptosis is essential for the resolution of
neutrophilic inflammation. To define the mechanisms triggering the
execution phase of apoptosis we developed and utilized a model in which culture of human neutrophils at 15 °C for 20 h arrested apoptosis and subsequent warming to 37 °C triggered a synchronous burst of
apoptosis. Treatment of 15 °C cultured neutrophils with the pan-caspase inhibitor zVAD-fmk just before warming to 37 °C
inhibited the morphological changes associated with apoptosis, but did
not prevent the insertion of the proapoptotic protein Bax into
mitochondria nor the inhibition of secretion and the externalization of
phosphatidylserine, indices of neutrophil apoptosis. In both intact
neutrophils and a cell-free extract, cytochrome c released
from mitochondria induced proteolytic cleavage of procaspase-3. At
15 °C the binding of Bax to mitochondria was uncoupled from Bax
insertion into the mitochondrial membrane required for the release of
cytochrome c. Apoptosis was also inhibited by low pH during
warming to 37 °C, suggesting that changes to the conformation of
Bax, necessary for membrane insertion, were being inhibited. Bax
insertion was only sensitive to zVAD-fmk when added at the start of the
15 °C culture period, suggesting that a cytoplasmic substrate of the effector caspases may mediate in the mechanism of Bax insertion into mitochondria.
 |
INTRODUCTION |
Successful resolution of the inflammatory response requires that
granulocytes, neutrophils and eosinophils, trigger an intracellular program for "silent" self-destruction called apoptosis (1, 2). If
cell-death occurs by necrosis the cytotoxic cargo of granulocyte
molecules is released, inducing tissue damage and chronic inflammation
and stimulating the release of proinflammatory macrophage products to
promote inflammation by other routes. The apoptotic program induces the
morphological hallmarks of apoptosis, nuclear condensation and cell
shrinkage, and shuts down the secretory potential of granulocytes (3).
Changes to the molecular profile of the surface of apoptotic
neutrophils target them for phagocytosis by macrophages (4, 5), without
release of proinflammatory mediators from macrophages (6).
Proinflammatory mediators and cytokines, such as granulocyte-macrophage
colony-stimulating factor, lipopolysaccharide, C5a, or an hypoxic
environment at the site of inflammation can prolong the functional life
span of granulocytes by delaying apoptosis (7, 8) through increased
expression of the anti-apoptotic proteins Bcl-XL (9) and
Mcl-1 (10). The molecular mechanism triggering the execution phase of
apoptosis in granulocytes is unknown but activation of tumor
necrosis factor and Fas (CD95) cell surface receptors
increase expression of the proapoptotic proteins Bax and procaspase-3
(9-14). Both the p38 mitogen-activated protein kinase and p42/p44
mitogen-activated protein kinase, and the transcription factor nuclear
factor- B, regulate the granulocyte apoptotic program (15, 16),
the signals transduced by these pathways converging to induce
activation of procaspase-3 (17-20).
In mammalian cells the execution phase of apoptosis involves either the
direct activation of procaspase-3 by caspase-8 (21), or indirect
activation of procaspase-3 through the release of apoptosis-inducing
factors, such as cytochrome c, from mitochondria (22-30).
The proapoptotic Bcl-2 family member Bax is a soluble, monomeric,
cytoplasmic protein (31) that inserts an hydrophobic C-terminal
membrane-spanning domain into mitochondria (32, 33), inducing release
of cytochrome c (31-35), triggering the activation of
caspase-3 (36-38) and the execution phase of apoptosis. Bax dimerization (39), the addition of recombinant Bax to isolated mitochondria (36) or overexpression of Bax (40) has also been shown to
induce the release of cytochrome c. The mechanism by which
cytochrome c is translocated from mitochondria into the cytoplasm is controversial (41). However, once in the cytoplasm cytochrome c complexes with apoptosis-protease-activating
factor-1 (Apaf-1) and procaspase-9 (26) to form a protein complex the "apoptosome" (42). In the presence of dATP this complex induces the
proteolytic cleavage and activation of procaspase-3 that triggers a
downstream cascade of caspase activity (43). It has been reported that
after differentiation and maturation neutrophils have a reduced number
of phenotypically atypical mitochondria, obtaining ATP predominantly by
glycolysis (10). Thus, whether mitochondria play a role in triggering
neutrophil apoptosis remains to be established.
Here we show that peripheral blood neutrophils cultured in
vitro at 15 °C for 20 h failed to induce the execution
phase of apoptosis until warmed to 37 °C, when they showed a
synchronous burst of apoptosis. In temperature-arrested neutrophils
endogenous Bax showed peripheral binding to mitochondria but failed to
induce activation of caspase-3 and apoptosis. On warming to 37 °C
Bax inserted into the neutrophil membranes with concomitant proteolytic cleavage of procaspase-3 and induction of apoptosis. In both intact neutrophils and cell-free neutrophil extracts we show that the proteolytic cleavage of procaspase-3 is induced by translocation of
cytochrome c into the cytoplasm. Analysis of plasma membrane events showed that externalization of phosphatidylserine and the inhibition of secretion were uncoupled from the activation of caspase-3, when the pan-caspase inhibitor
benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone
(zVAD-fmk)1 was added to
15 °C cultured neutrophils before warming them to 37 °C. Under
these conditions the caspase inhibitor did not prevent Bax insertion
into mitochondria when the cells were warmed from 15 to 37 °C.
However, surprisingly, Bax insertion was inhibited if zVAD-fmk was
added to neutrophils at the start of their incubation at 15 °C. This
experimental model of apoptosis has provided insights into the
molecular mechanisms that trigger the execution phase of neutrophil apoptosis.
 |
EXPERIMENTAL PROCEDURES |
Granulocyte Isolation and Culture--
Neutrophils were purified
on gradients of PercollTM from Amersham Pharmacia Biotech (Bucks,
United Kingdom) (44). They were cultured in Tuf-TainerTM TeflonTM
pots from Pierce & Warriner Ltd. (Chester, UK) at 5 × 106 cells/ml in growth medium containing: Iscove's
modified Dulbecco's medium supplemented with 2 mM
glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, and 10%
(v/v) autologous serum. Culture at 15 °C was in growth medium
containing: 25 mM Hepes-NaOH, pH 7, 0.2% (w/v)
endotoxin-free bovine serum albumin (BSA), and 20 µg/ml
cycloheximide. BSA and all other chemicals were from Sigma. Neutrophil
preparations were 98% pure with <2% eosinophil contamination (16).
Granulocytes from atopic donors were used to purify eosinophils by a
negative selection procedure (16). Incubations with zVAD-fmk from
BACHEM Ltd. (Essex, UK), staurosporine from CN Biosciences (Nottingham,
UK), and bongkrekic acid from BIOMOL Research Laboratories Inc.
(Plymouth Meeting, PA) were in Iscove's medium with 0.2% (w/v) BSA
and 20 µg/ml cycloheximide.
Assessment of Granulocyte Apoptosis--
Nuclear morphology was
assessed on cytocentrifuged slides stained with Diff-QuikTM Gamidor
Ltd. (Abingdon, Oxon, UK) (16). Annexin V-FITC, from BenderMed Systems
(Vienna, Austria), was used at 1:200 dilution (5 × 105 cells/ml) to assay phosphatidylserine externalization
and propidium iodide (10 µg/ml in
Ca2+/Mg2+-free phosphate-buffered saline) was
used to monitor membrane integrity by flow cytometry on an EPICS
Profile II from Coulter Electronics (Luton, UK) (16). DNA fragmentation
was detected by the TUNELTM in situ cell death detection
kit from Roche Molecular Biochemicals (East Sussex, UK) and by sizing
of DNA fragments on agarose gels, capturing images using a GS 1600m gel
documentation system Ultra-Violet Products Ltd. (Cambridge, UK) (16,
45). The data is representative of at least three experiments unless indicated.
Measurement of Intracellular pH--
Neutrophils (5 × 104 cells) in 100 µl of Hank's buffered saline,
supplemented with 20 mM Hepes-NaOH, pH 7.4, 5 mM glucose, 0.2% (w/v) BSA, and 10 µM
SNARF-1/AM from Molecular Probes (Eugene, OR) were incubated for 10 min
at 37 °C. Intracellular SNARF-1 was excited at 488 nm and emission
was measured at 575 and 670 nm using linear amplifiers and data plotted
as forward scatter versus fluorescence ratio (FL2/FL3). The
intracellular pH (pHi) was determined by comparing mean 575/670
nm fluorescence ratio values of histograms, to a calibration curve of
histograms from fresh neutrophils. The pH was clamped between 5.6 and
7.8, with overlapping 0.2 pH unit intervals, in 20 mM Mes,
Pipes, and Hepes buffers and 2 µg/ml nigericin, in a high-potassium
medium containing: 110 mM KCl, 20 mM NaCl, 5 mM glucose, 1 mM MgCl2, 1.5 mM CaCl2, 0.2% (w/v) BSA.
Preparation of Cytosol from 15 °C
Neutrophils--
Neutrophils (5 × 108; <5%
apoptotic after 20 h at 15 °C) were sedimented at 1,500 × gav at 4 °C. They were washed twice in 50 ml
of homogenization buffer: 15 mM Pipes-NaOH, pH 7.4, 80 mM KCl, 20 mM NaCl, 0.25 M sucrose,
1 mM dithiothreitol, and a 1:1000 dilution of protease
inhibitor mixture: 87 mg of phenylmethylsulfonyl fluoride, 160 mg
benzamidine, and 10 mg of leupeptin and aprotinin, and 5 mg each of
bestatin, antipain, chymostatin, and pepstatin A solubilized in 1 ml of
Me2SO. Neutrophils were resuspended in 1 ml of
homogenization buffer then broken with 20-30 strokes of a
tight-fitting pestle in a glass Dounce homogenizer from Wheaton (Millville, NJ), until 80% of the nuclei stained with trypan blue. Intact cells and nuclei were removed by centrifugation at 350 × gav for 5 min at 4 °C. Post-nuclear
supernatants were centrifuged at 17,000 × gav in a TLA 100.3 rotor from Beckman (High
Wycombe, Bucks, UK) for 10 min to remove secretory granules and
mitochondria and the supernatant centrifuged at 541,000 × gmax for 15 min in a TLA 100.3 rotor to yield a
membrane-free cytosol. Cytosol (200 µl) was frozen and stored in
liquid nitrogen. Protein concentrations were assayed by the bicinchonic
acid protocol from Pierce & Warriner Ltd. The immunoprecipitation
procedure, with a monoclonal antibody to a native cytochrome
c epitope (6H2.B4, PharMingen), was as described previously
(46).
Cell-free Proteolytic Cleavage of Procaspase-3--
Cell-free
mixtures for the proteolytic cleavage of procaspase-3 contained: 10 µl of 15 °C cytosol (50 mg of protein/ml) and 10 µl of an assay
dilution buffer containing: 10 mM Hepes-NaOH, pH 7.4, 40 mM -glycerophosphate, 50 mM NaCl, 2 mM MgCl2, 5 mM EGTA, 1 mM dithiothreitol, supplemented with dATP (20 µM) and inhibitors where appropriate. Incubations were
stopped by transferring samples to ice and adding 20 µl of 50 mM Tris-HCl, pH 8, 0.4 M NaCl, 1% (w/v)
deoxycholate, 1% (w/v) Nonidet P-40, 5 mM EDTA, containing
protease inhibitor mixture (lysis buffer) for 0.5 h.
Isolation of Mitochondria--
Rat liver was washed in 10 mM Pipes-NaOH, pH 7.2, 0.25 M sucrose, 2 mM EDTA and protease inhibitor mixture then forced through a stainless steel sieve (150 µm aperture; Endecotes Ltd., London) to
break cells (46). The mitochondria were isolated from a post-nuclear supernatant as described previously and washed in the assay dilution buffer described above (47).
SDS-PAGE and Immunoblotting--
Assay samples (40 µl),
treated with ice-cold lysis buffer for 0.5 h (40 µl) were
solubilized with 80 µl of 2 × SDS-PAGE sample buffer (46) at
95 °C for 10 min, then treated with 1 mM dithiothreitol, cooled, and treated with 10 mM iodoacetamide. The proteins
were separated on 12% (w/v) polyacrylamide gels and
electrophoretically transferred to nitrocellulose (46). The blots were
probed with monoclonal antibodies to procaspase-3 (clone 19) and
procaspase-7 (clone 51) from Transduction Laboratories (Lexington, KY)
and monoclonal antibodies to procaspase-8 (clone B9-2), procaspase-9 (clone B40), cytochrome c (clone 7H8.2C12), and polyclonal
human Bax (13666E) all from PharMingen (San Diego, CA), at dilutions of
1:500-1:1000. A hybridoma supernatant to poly(ADP-ribose)polymerase (PARP), used at 1:500 dilution, was a gift from Said Aoufuchi (Laboratory of Molecular Biology, Cambridge, UK). The horseradish peroxidase-conjugated anti-mouse and anti-rabbit IgGs from Kirkegaard & Perry Labs (Gaithersburg, MA) were used at 1:4000 dilution for 0.5 h and detected by enhanced chemiluminescence (46). The level of protein
loading and nonspecific proteolysis were monitored by Ponceau S
staining (46). Tubulin and actin were assayed with anti-bovine
-tubulin monoclonal antibody (236-10501) from Molecular Probes and a
monoclonal antibody to actin; a gift from Simon Brown (Center for
Inflammation Research, University of Edinburgh).
Confocal Microscopy--
Neutrophils (105 cells in
100 µl of medium) were cytocentrifuged (300 rpm for 3 min) onto
1.5 × 22 × 22-mm glass coverslips and fixed in
methanol-free 3% (w/v) p-formaldehyde/phosphate-buffered saline and processed for immunofluorescence microscopy as described previously (46). The fixed cells were permeabilized with 0.1% (w/v)
Triton X-100 and nonspecific binding sites blocked for 1 h with
0.2% (w/v) fish skin gelatin and 20% (v/v) sheep serum in
phosphate-buffered saline. A monoclonal antibody to mitochondrial heat
shock protein 70 (mtHSP70) from Affinity Bioreagents Inc. (Golden, CO)
and a rabbit polyclonal antibody to ubiquinol-cytochrome c
oxidoreductase (complex III) produced by Herman Schagger (University of
Frankfurt-am-Main), were used at 1:200 dilution to stain mitochondria. The polyclonal antibody to human Bax was used at 1:200 dilution. The
secondary antibodies used at 1:400 dilution were AlexaTM 488 (green)
goat anti-mouse IgG (highly cross-adsorbed) and AlexaTM 568 (red) goat
anti-rabbit (highly cross-adsorbed) and the nucleic acid stain
TOPO-3TM (8 µM), from Molecular Probes. Cells were
observed using a ×63 water immersion objective lens with a numerical
aperture of 1.2 on a Leica TCS NT confocal laser scanning microscope
system (Heidelberg, GMBH). Single optical sections of the images
captured with Leica TCS software were digitally processed using Adobe
Photoshop 5.02 and Paint Shop Pro 4.
 |
RESULTS |
Neutrophil Apoptosis Is Arrested at 15 °C--
Neutrophils from
peripheral blood can be maintained in culture at 37 °C for several
hours in autologous serum before asynchronously undergoing apoptosis
(Fig. 1A, closed
squares). Apoptosis was quantified using annexin V-FITC binding to
externalized phosphatidylserine and morphological counting of pyknotic
nuclei (16). A synchronous commitment to apoptosis has previously been
induced in cells by using cell-free systems (28, 47-49). Dividing
cells, for example, blocked at cell cycle checkpoints provide an
homogeneous cytosol (49). Although neutrophils are terminally
differentiated (post-replicative) cells, we synchronized their
commitment to the execution phase of apoptosis by exposure to low
temperature.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 1.
Human neutrophil apoptosis was
arrested at 15 °C and warming to 37 °C induced a rapid and
synchronous apoptosis. Neutrophils were cultured in medium
supplemented with: A, 0.2% BSA and 20 µg/ml cycloheximide
at 15 °C ( ) and 37 °C ( ), an incubation with 10% (v/v)
autologous serum, without cycloheximide at 37 °C is also shown
( ). Apoptosis was assessed by annexin V-FITC binding analyzed by
flow cytometry. B, neutrophils cultured and analyzed as
described in A were held at 15 °C for 20 h ( ),
and subsequently warmed to 37 °C, . C, neutrophils
were cultured at 15 °C as described in A and at 1-h
intervals harvested and warmed to 37 °C for 1.5 h as described
in B to assess the initial rate of apoptosis (single
experiment). D, DNA, extracted from 5 × 106 neutrophils cultured at 15 °C for 20 h and
warmed to 37 °C as described in B, was separated in
agarose gels and stained with ethidium bromide. A 1-kilobase ladder of
DNA standards (Std) is shown. Annexin V-FITC binding was used to assess
apoptosis and the percentage (%) apoptosis for each sample is
shown.
|
|
Low temperature blocks intracellular pathways that rely on membrane
fission and fusion, as exemplified by vesicular transport (50, 51). In
neutrophils (Fig. 1A, open circles) or
eosinophils (data not shown) cultured at 15 °C, apoptosis was
arrested suggesting that a membrane-associated event required for
apoptosis was inhibited. In contrast, culture of HL-60 promyelocytic
leukemia cells at 15 °C induced apoptosis (data not shown) as
described previously for these and many other dividing mammalian cells
(52), suggesting that there may be cell-type or differentiation
state-dependent pathways for apoptosis. The rate of
neutrophil apoptosis at 37 °C was accelerated by treatment with
cycloheximide (Fig. 1A, closed circles). In
addition to preventing the translation of new proteins in the
cytoplasm, cycloheximide can induce apoptosis through
FADD-dependent mechanisms downstream of cell-surface Fas
death receptors (53). However, when we cultured neutrophils at 15 °C
with cycloheximide there was no increase in the rate of apoptosis (Fig.
1A, open circles). Treatment of 15 °C cultured
neutrophils with tumor necrosis factor (16) did not induce
apoptosis (data not shown), suggesting that the block to the induction
of the execution phase of apoptosis was downstream of these plasma
membrane-associated events.
Temperature Shift to 37 °C Triggers Synchronous
Apoptosis--
The low temperature arrest of neutrophil apoptosis was
reversed by re-warming neutrophils, cultured for 20 h at 15 °C,
to 37 °C. There was reorganization of the cytoskeleton associated with cell polarization (shape-change), monitored by flow cytometry, that showed cytoskeletal integrity had been maintained at 15 °C (data not shown). This polarization of the neutrophils was followed by
a burst of synchronous apoptosis (Fig. 1B, closed
circles). The initial rate of apoptosis was 10-fold greater than
the rate of constitutive apoptosis in neutrophils maintained at
37 °C (Fig. 1A, closed squares), and by 2 h after warming 80-90% of the cells were apoptotic (Fig.
1B, closed circles). Neutrophils maintained for a
further 2 h at 15 °C showed no shape change and no increase in
their rate of apoptosis (Fig. 1B, open circles).
By culturing neutrophils in medium containing BSA and cycloheximide we
removed experimental variables induced by serum factors and translation of mRNA into new protein.
The accelerated rate of neutrophil apoptosis at 37 °C, following
preincubation at 15 °C, depended on the period of time neutrophils had been cultured at 15 °C. It was not a cold-shock response, as
previously shown for lymphocytes (54). We demonstrated this by
maintaining cells at 15 °C for increasing periods of time before warming them to 37 °C and estimating the initial rate of apoptosis over a 1.5-h period as shown in Fig. 1B (closed
circles). For the first 6 h in culture there was no increase
in the initial rate of apoptosis (Fig. 1C). However, as the
cells were cultured for longer periods at 15 °C there was an
increase in the initial rate of apoptosis on warming (Fig.
1C). These data suggested that there was a time- and
temperature-dependent accumulation of a proapoptotic factor
at the site of the temperature arrest that led to a synchronization of
apoptosis when the cells were subsequently warmed to 37 °C. DNA
laddering (Fig. 1D), a downstream hallmark of activation of
the execution phase of apoptosis, showed kinetics similar to the
morphological and annexin V-FITC estimates of apoptosis when 15 °C
cultured neutrophils were warmed to 37 °C.
15 °C Arrest Is Proximal to Procaspase-3 Activation--
To
establish whether inhibition of neutrophil apoptosis at 15 °C (Fig.
2A, open circles)
was upstream of caspase-3 activation and apoptosis at 37 °C (Fig.
2A, closed circles), 15 °C cultured neutrophils were treated with 100 µM zVAD-fmk (18) (Fig.
2A, open squares) for 15 min before warming to
37 °C. zVAD-fmk inhibited chromatin condensation and the formation
of pyknotic nuclei when neutrophils were warmed from 15 to 37 °C
(Fig. 2A, closed squares). DNA fragmentation at
37 °C (Fig. 2B, closed circles), indicative of
caspase-3 activation, was also inhibited (Fig. 2B,
closed squares) by zVAD-fmk. Phosphatidylserine was still
translocated to the cell surface in the presence of zVAD-fmk (Fig.
2C, closed squares), although the kinetics of
translocation were significantly different from the untreated
neutrophils (Fig. 2C, closed circles).
Phosphatidylserine externalization has been linked to caspase-3
activity (19, 55-57) so their uncoupling was surprising. However, two
other plasma membrane hallmarks of apoptosis phagocytosis (57) and
regulated secretion2 were
also uncoupled from caspase-3 by zVAD-fmk. The protein kinase inhibitor
staurosporine together with cycloheximide induces apoptosis in many
cells (58). However, staurosporine did not stimulate apoptosis at
15 °C (Fig. 2D, open squares) nor did it
accelerate the induction of morphological apoptosis when neutrophils
were warmed to 37 °C (Fig. 2D, closed
squares). Phosphatidylserine, detected on the cell surface by
annexin-V-FITC after warming to 37 °C (Fig. 2E,
closed circles), was not detected in the presence of
staurosporine (Fig. 2E, closed squares),
suggesting that translocation of this phospholipid to the cell surface
may rely on a critical phosphorylation event. The inhibition of
mitochondrial respiration also blocks phosphatidylserine
externalization in apoptotic U937 and THP.1 cells, suggesting that this
may be an energy-dependent event (57). Okadaic acid, an
inhibitor of phosphatases 1 and 2A (46) had no effect on the induction
of apoptosis in 15 °C cultured neutrophils warmed to 37 °C (Fig.
2F, closed squares). This suggested that caspase
activation might not be modulated by phosphorylation events in this
experimental model. A number of other agents that induce neutrophil
apoptosis, such as the nuclear factor- B inhibitor gliotoxin (16)
and the phosphatidylinositol kinase inhibitor wortmannin, had no effect
on the rate of apoptosis in 15 °C cultured neutrophils (data not
shown). Our results suggest that the temperature-dependent
arrest of apoptosis in neutrophils was not due to signal transduction
nor gene transcription events.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 2.
zVAD-fmk inhibited morphological
apoptosis but not the externalization of phosphatidylserine that is
inhibited by staurosporine but not okadaic acid. Effects of the
global caspase inhibitor zVAD-fmk on the triggering of neutrophil
apoptosis. A, neutrophils were cultured, as described in the
legend to Fig. 1A, at 15 °C for 20 h ( , ) and
warmed to 37 °C ( , ) and apoptosis estimated by morphological
counting. The neutrophils were treated with 100 µM
zVAD-fmk for 15 min ( , ) prior to warming to 37 °C and control
neutrophils were mock treated with Me2SO ( , ).
B, DNA fragmentation in the 15 and 37 °C neutrophils
shown in A was analyzed by TUNELTM and flow cytometry.
C, the externalization of phosphatidylserine at the surface
of the neutrophil plasma membrane at 15 °C ( , ) and 37 °C
( , ) was estimated by annexin V-FITC binding for the samples
shown in A above. D, staurosporine inhibited
phosphatidylserine externalization. Apoptosis, assessed by
morphological counting for neutrophils warmed from 15 °C ( ) to
37 °C ( ) was not inhibited by 2 µM staurosporine
treatment of 15 °C cultured neutrophils ( ) for 1 h prior to
warming to 37 °C ( ). E, however, the externalization
of phosphatidylserine, assessed by annexin V-FITC-binding, at 15 °C
( ), and after warming to 37 °C ( ) was inhibited by
treatment with staurosporine ( , ). F,
neutrophils were cultured at 15 °C for 20 h ( ) and before
warming to 37 °C ( ) they were treated at 15 °C ( ) for
1 h with the 1 µM okadaic acid then warmed to
37 °C ( ) and showed no inhibition of the triggering of apoptosis
assessed by annexin V-FITC binding.
|
|
A Low Intracellular pH Inhibits the Triggering of
Apoptosis--
Acid conditions at sites of inflammation inhibit
neutrophil apoptosis (59), but conversely, low pH has also been
implicated in triggering apoptosis in many cells (60, 61). The
pHi of freshly isolated neutrophils was 7.1, equivalent to the
"set point" for resting cells in culture when measured by
accumulation of carboxy-seminaphthorhodafluor-1 (SNARF-1), a
fluorescent probe whose emission changes with pH (61-63). The
pHi of neutrophils incubated at 15 °C for 20 h was
6.8-7.0 (Fig. 3A, open
circles). However, following the induction of apoptosis (assayed
by annexin-V-binding and morphology, Fig. 3, B and
C), by increasing the temperature to 37 °C the
pHi dropped to 6.4 (Fig. 3A, closed
circles) as apoptosis progressed (Fig. 3B, closed
circles), consistent with previous measurements of acidic
pHi during apoptosis (60, 61). However, clamping neutrophils at
pH 6.2, with nigericin and high K+ (Fig. 3A,
squares) did not trigger apoptosis at 15 °C (Fig. 3, B, open squares, and C) or at 37 °C
(Fig. 3, B, closed squares, and C).
This suggested that acid pH alone was not a sufficient trigger for
apoptosis as previously suggested (60, 61). Neutrophils cultured in
growth-medium buffered at pH 6.2, in the absence of nigericin (Fig.
3A, triangles), did not induce apoptosis at
15 °C (Fig. 3,B, open triangles, and
C) nor on warming to 37 °C (Fig. 3, B,
closed triangles, and C). This in
vitro response to low pH appears to mimic the arrest of neutrophil
apoptosis at inflammatory foci where the pH has dropped below 7 (59).
When the pHi of 15 °C cultured neutrophils was clamped at
7.2, the rate of apoptosis was significantly greater when the cells
were warmed to 37 °C (Fig. 3D, squares) than
in cells clamped at pH 6.2 (Fig. 3D, closed
triangles). However, apoptosis was still not as efficient as in
the untreated cells (Fig. 3D, closed circles).
This result is, however, consistent with reports that suggest an
alkaline pH transient is necessary to trigger the execution phase
of apoptosis (64).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
Acid pH arrested the triggering of apoptosis
following a shift in temperature from 15 to 37 °C.
A, neutrophils were cultured at 15 °C for 20 h then
either maintained at an external pH of 7.2 at 15 °C ( ) or
37 °C ( ) for 1.5 h, clamped at pH 6.2 in a high-potassium
buffer containing nigericin to maintain a pHi of 6.2 when
cultured at 15 °C ( ) or warmed to 37 °C ( ) for 1.5 h
or exposed to an external pH of 6.2, in the absence of any added
nigericin and potassium, at 15 °C ( ) or 37 °C ( ).
B, apoptosis for the samples shown in A was
assessed by annexin V-FITC-binding at 15 °C ( , , ) and
37 °C ( , , ) for neutrophils exposed to an external pH of
7.2 ( , ) or 6.2 ( , ) or clamped at pH 6.2 with nigericin in
a high potassium buffer ( , ). C, morphological
estimates for neutrophil apoptosis of samples in B above at
1.5 h after warming from 15 to 37 °C and for neutrophils
exposed to external pH of 6.2 (pH 6.2) or clamped with nigericin and
potassium (pH 6.2 N). D, apoptosis estimated by
annexin-V-FITC binding for neutrophils cultured at 15 °C for 20 h and either held at 15 °C ( ) or warmed to 37 °C ( ) and
their pHi clamped at either 7.2 ( , ) or 6.2 ( , ) in
a high potassium buffer containing nigericin.
|
|
Neutrophil Apoptosis Is Correlated with Procaspase-3
Cleavage--
Procaspase-3 cleavage is required for neutrophil
apoptosis (65), but was not detected by immunoblotting in freshly
isolated human neutrophils (Fig.
4A, lane 2). However,
treatment of neutrophils with diisopropyl fluorophosphate, a serine
protease inhibitor, before solubilization at 0 °C in a nondenaturing
lysis buffer and SDS sample buffer for PAGE, prevented nonspecific
proteolysis of procaspase-3 (Fig. 4A, lane 3). Neutrophils
were treated with diisopropyl fluorophosphate before isolating
cytosols, but while this was not absolutely necessary for 15 °C
cultured neutrophils (Fig. 4A, lanes 4 and 5),
diisopropyl fluorophosphate treatment did allow detection of endogenous
procaspase-7 and procaspase-8 by immunoblotting. We have been unable to
detect procaspase-9 (data not shown).

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 4.
Temperature-dependent
proteolytic cleavage of endogenous procaspase-3 in intact
neutrophils. A, freshly isolated human
neutrophils (PMN) (lanes 2 and 3) and
neutrophils cultured at 15 °C for 20 h (lanes 4 and
5) were either treated with 2.3 mM diisopropyl
fluorophosphate for 15 min on ice (lanes 3 and 5)
or left untreated (lanes 2 and 4). Each lane
contains 80 µg of protein solubilized in lysis buffer on ice then in
SDS sample buffer before separation on a 12% (w/v) polyacrylamide gel
and electrophoretic transfer to nitrocellulose sheets and probing with
a monoclonal antibody to procaspase-3. Lane 1 shows cytosol
from 15 °C cultured neutrophils. B, neutrophils cultured
at 15 °C, as described in the legend to Fig. 1, and cell pellets
(5 × 106 cells) were solubilized and analyzed
as described in A. The 15 °C cultured neutrophils were
either warmed to 37 °C (upper panel, lanes 1-11) or held
at 15 °C (lower panel, lanes 1-11) for the
times indicated and proteolytic cleavage of procaspase-3 assessed by
immunoblotting. Re-probing the blots with antibodies to tubulin or
actin (not shown) assessed protein loading and nonspecific
proteolysis.
|
|
Neutrophils cultured at 15 °C for 20 h, when warmed to 37 °C
for 2 h, proteolytically cleaved procaspase-3 in a
time-dependent manner (Fig. 4B, upper
panel, lanes 1-11) that correlated with estimates of
apoptosis by counting of pyknotic nuclei and annexin V-FITC binding
(Fig. 2, A and C). Neutrophils held for a further 2 h at 15 °C showed no proteolytic processing of procaspase-3 (Fig. 4B, lower panel, lanes
1-11).
Proapoptotic Events Can be Detected in Neutrophil Cytosols--
To
identify the molecular events leading to the proteolytic cleavage and
activation of neutrophil procaspase-3, cytosols were prepared from
cultures of neutrophils maintained at 15 °C for 20 h. The
neutrophils were homogenized in buffered sucrose and fractionated using
a two-step ultracentrifugation procedure (see "Experimental
Procedures") to minimize damage to organelles, particularly secretory
granules. Elastase, a secretory granule marker, sedimented with
membrane fractions (data not shown), while procaspase-3 remained in the
cytosol (Fig. 5A, lane 1).
Neutrophils cultured at 15 °C and warmed to 37 °C for 1.5 h
before preparing the cytosols did not contain procaspase-3 (Fig.
5A, lane 2). The proteolytic cleavage of procaspase-3,
observed in unbroken 15 °C cultured neutrophils warmed to 37 °C
(Fig. 4B, lanes 5-11), had presumably been triggered by
apoptosis-inducing factors released from the membranes into the
cytoplasm before the cells had been homogenized. Significantly, when
cytosols from 15 °C cultured neutrophils were warmed to 37 °C in
the presence of dATP, a cofactor involved in the activation of the
apoptosome (42), procaspase-3 was not proteolytically cleaved
(Fig. 5A, lane 5) and was present in an amount
comparable to the zVAD-fmk-treated controls (Fig. 5A, lane
6). These data suggested that apoptosis-inducing factors were
missing from the cytosol and had been removed with the membrane
fraction. The fraction of cytosol from the small number of
contaminating apoptotic cells did not catalyze a significant rate of
proteolytic cleavage of procaspase-3.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 5.
Cell-free proteolytic cleavage of
procaspase-3. A, the proteolytic cleavage of endogenous
neutrophil procaspase-3 was analyzed in cytosol supplemented with 20 µM dATP (lanes 1, 3-6), and in 15 °C
cultured neutrophil cytosol warmed to 37 °C (lane 2) by
immunoblotting. Samples of the 15 °C cytosol (lane 1) and
cytosol from 15 °C cultured cells warmed to 37 °C (lane
2) were held at 0 °C. The 15 °C cytosol was also held at
15 °C (lane 3) or warmed to 37 °C (lane 5)
in the presence (lanes 4 and 6) or absence
(lanes 3 and 5) of 100 µM zVAD-fmk.
B, cell-free assays containing cytosol from 15 °C
cultured neutrophils were supplemented with 5 µl of rat liver
mitochondria fraction (47) and incubated at 15 °C for the times
indicated (lanes 1-5, respectively). Control incubations at
15 °C contained: 100 µM zVAD-fmk (lane 6),
mitochondria plus 0.1% (w/v) Triton X-100 (lane 7), or no
mitochondria (lane 8). Lanes 9-12 show
incubations at 37 °C for the times indicated, a zVAD-fmk 2 h
control (lane 13), a mitochondria plus 0.1% (w/v) Triton
X-100 control (lane 14), and a control lane with no added
mitochondria (lane 15). C, the rate of neutrophil
apoptosis is temperature dependent. Neutrophils were incubated for
22 h at 15 °C and then warmed to the given temperatures
(between 15 and 40 °C). The rate of apoptosis was estimated by
annexin V-FITC binding as described in the legend for Fig.
1B. D, induction of the proteolytic cleavage of
procaspase-3 by horse heart cytochrome c. Incubations and
analysis were as described above in A and were for 1 h
at the temperatures shown. Lane 1, 37 °C cytosol control.
In lanes 2-6 the assays were supplemented with 200 ng of
cytochrome c. Incubations were at 15 °C (lanes
2 and 3), 37 °C (lanes 4 and
5), and 0 °C (lane 6). Controls containing 100 µM zVAD-fmk are shown in lanes 1, 3, and
5.
|
|
Mitochondria have been shown to play a key role in the control and
amplification of apoptotic signals (23, 42). Cytosols from
Xenopus laevis eggs only trigger apoptosis when membrane fractions enriched in mitochondria are added (25, 27, 48). When rat
liver mitochondria were added to cytosols isolated from 15 °C
cultured neutrophils, supplemented with dATP then incubated at 15 °C
for 2 h, immunoblotting revealed no significant proteolytic processing of procaspase-3 (Fig. 5B, lanes 1-5). The degree
of proteolytic processing was compared with 15 °C cytosols
pretreated with zVAD-fmk (Fig. 5B, lane 6) and with 15 °C
cytosols without added mitochondria (Fig. 5B, lane 8). In
cytosols containing dATP and mitochondria permeabilized with Triton
X-100, to release apoptosis-inducing factors, an efficient proteolytic
cleavage of procaspase-3 was observed by 2 h at either 15 or
37 °C (Fig. 5B, lanes 7 and 14). Cytosol from
15 °C neutrophils warmed to 37 °C with rat liver mitochondria,
and dATP induced proteolytic cleavage of procaspase-3 in a
time-dependent manner (Fig. 5B, lanes 9-12).
The protease activity was inhibited by zVAD-fmk (Fig. 5B, lane
13) and was dependent upon the addition of mitochondria at
37 °C (Fig. 5B, lane 15).
The involvement of membrane-associated events in the triggering of
neutrophil apoptosis was also suggested by analysis of the rate of
apoptosis as a function of temperature (Fig. 5C). There was
a sharp decline in the rate of apoptosis below 20 °C and an
Arrhenius plot of this data (not shown) (66) showed that the
temperature dependence was biphasic. As the temperature drops to
15 °C reduction in the fluidity of the membrane lipid may affect the
behavior of membrane-associated proteins (50, 51, 66). Mitochondrial
anion channels have also been shown to respond to lowered temperature
by changing their probability of being open, a parameter that is also
affected by changes in pH (67). Thus, in our cell-free assay low
temperature maintained the segregation of apoptosis-inducing factors
within mitochondria, preventing apoptosome activation.
Cytochrome c Induces Procaspase-3 Cleavage--
When horse heart
cytochrome c and dATP were added to cytosol from 15 °C
cultured neutrophils and incubated at 15 or 37 °C for 1 h,
proteolytic cleavage of procaspase-3 was induced (Fig. 5D, lanes
2 and 4). The kinetics of procaspase-3 proteolytic
cleavage were dependent on the concentration of cytochrome
c, being complete between 10 and 100 ng of cytochrome
c/80 µg of cytosol protein after 1 h at 37 °C.
Treatment of the neutrophil cytosol with 100 µM zVAD-fmk
prior to the addition of cytochrome c prevented proteolytic cleavage of procaspase-3 at 15 and 37 °C (Fig. 5D, lanes
3 and 5). Since an efficient proteolytic cleavage of
procaspase-3 occurred at 15 °C the arrest of apoptosis was
unlikely to be a consequence of the failure of the apoptosome proteins
to undergo conformational changes at low temperature (68).
Poly(ADP-ribose)polymerase Is Cleaved by 15 °C
Cytosols--
Neutrophil cytosols containing cytochrome c
and dATP produced active caspase-3 that processed HL-60 PARP (116 kDa),
not present in mature neutrophils (17), to an 85-kDa polypeptide
fragment after a 1.5-h incubation at 15 °C (Fig.
6, lower panel, lane 3). This
proteolytic cleavage was inhibited by zVAD-fmk (Fig. 6, lower panel, lane 4). There was no apparent proteolysis of
procaspase-3 under these conditions (Fig. 6, upper panel,
lane 3). There was variability between cytosol preparations,
and under similar conditions procaspase-3 was fully processed (see
Fig. 5D, lane 2). At 37 °C there was complete proteolytic
cleavage of procaspase-3 (Fig. 6, upper panel, lane
5) with concomitant proteolytic cleavage of PARP (Fig. 6,
lower panel, lane 5); again this was inhibited by
zVAD-fmk (Fig. 6, lower panel, lane 6). No
proteolytic processing of neutrophil procaspase-3 or HL-60-PARP by
endogenous proteases was detected in the absence of cytochrome
c (Fig. 6, upper panel, lane 1, and
lower panel, lane 7, respectively).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 6.
Proteolytic processing of HL-60 PARP in
heterologous cell-free assays. HL-60 nuclei were incubated with
15 °C neutrophil cytosol and dATP and proteolytic cleavage of
procaspase-3 triggered by the addition of cytochrome c (200 ng). Samples were taken at 0 h (lane 2) and at 1.5 h after incubation at 15 °C (lanes 3 and 4),
without zVAD-fmk treatment (lanes 1-3, 5 and
7), with 100 µM zVAD-fmk treatment
(lanes 4 and 6), and after incubation at 37 °C
(lanes 1 and 5-7). Samples were solubilized as
described in the legend to Fig. 5B and the immunoblots
probed with monoclonal antibodies to procaspase-3 (upper
panel) and PARP (lower panel).
|
|
Release of Cytochrome c from Neutrophil Mitochondria Occurs at 37 but not 15 °C--
Cytochrome c induced the proteolytic
cleavage of endogenous neutrophil procaspase-3 but there was the
possibility that this was only a property of the cell-free assay,
particularly since we were unable to detect procaspase-9 a component of
the apoptosome (42). To monitor translocation of cytochrome
c from mitochondria into the cytoplasm of intact
neutrophils, warmed from 15 to 37 °C, we separated postnuclear
supernatants into membrane and cytosol fractions. Cytochrome
c was immunoprecipitated from the fractions with a
monoclonal antibody to a native cytochrome c epitope and identified by immunoblotting with an anti-cytochrome c
antibody that recognized SDS-denatured cytochrome c.
Neutrophil cytochrome c (Fig.
7, lane 3) co-migrated with
cytochrome c from both horse heart and HeLa cells (Fig. 7,
lanes 1 and 2). In neutrophils held at 15 °C,
cytochrome c remained with the membrane fraction (Fig. 7,
lanes 4 and 5), but on warming to 37 °C
cytochrome c was translocated to the cytosol (Fig. 7,
lanes 7 and 8). Thus neutrophils released endogenous cytochrome c from mitochondria into the
cytoplasm, an event that correlated with the onset of apoptosis.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
The release of endogenous neutrophil
cytochrome c from membrane fractions into the
cytosol. Neutrophils were cultured at 15 °C as described in the
legend to Fig. 1A. Samples were solubilized in a
nondenaturing lysis buffer for immunoprecipitation (46) with monoclonal
antibodies to a native epitope on cytochrome c. After
SDS-PAGE and electroblotting to nitrocellulose, cytochrome c
was identified with a monoclonal antibody to the SDS-denatured form of
cytochrome c. Lane 1 contains 50 ng of horse
heart cytochrome c (C). Lane 2 shows
an immunoprecipitation of cytochrome c from 0.5 × 106 HeLa cells (H). Lanes 3-8 show
cytochrome c immunoprecipitated from: in lane 3,
a post-nuclear supernatants (P) of 15 °C cultured
neutrophils (7.5 × 107 cells); lane 4,
15 °C cultured neutrophil membrane fraction (M);
lane 5, 15 °C cultured neutrophil supernatant
(S) fraction; lane 6, post-nuclear supernatants
(S) of 15 °C cultured neutrophils warmed to 37 °C for
2 h (apoptosis by annexin V-FITC 85%); lane 7,
37 °C membrane fraction (M); lane 8, 37 °C supernatant
(S) fraction.
|
|
The Translocation of Bax to Membrane Fractions--
How the
mitochondrial membrane is permeabilized to release cytochrome
c during apoptosis is not known (68, 69). However, while the
opening or formation of the putative membrane channels may be
temperature-sensitive, movement of cytochrome c through the
channels may not be sensitive to reduced temperature (30). Bax is
highly expressed in neutrophils (9-14) and can form membrane pores
(39) so we examined the subcellular distribution of Bax during
neutrophil apoptosis. Immunoblotting showed that Bax was present in the
postnuclear supernatants of 15 °C cultured neutrophils (Fig.
8, upper panel, lane 1).
Sedimentation of the membranes by ultracentrifugation (Fig. 8,
upper panel, lane 2) showed that Bax partitioned
into the cytosol (Fig. 8, upper panel, lane 3) with
procaspase-3 (Fig. 8, lower panel, lane 3). This
is consistent with their localization in freshly isolated neutrophils
(data not shown), murine thymocytes, splenocytes, and HL-60 cells (33, 35). In 15 °C cultured neutrophils warmed to 37 °C for 3 h, procaspase-3 was proteolytically cleaved (Fig. 8, lower
panel, lanes 4-6) and Bax had translocated to the
washed membrane fraction (Fig. 8, upper panel, lane
5) from the cytosol (Fig. 8, upper panel, lane
6). This location suggested that Bax had inserted its hydrophobic
membrane-spanning domain into mitochondria (40). In some experiments
membrane-associated Bax was processed to an 18-kDa fragment (data not
shown), a cleavage product identified in a number of other apoptotic
cells (70, 71).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 8.
Subcellular localization of Bax.
Neutrophils (3 × 108 cells) were held at 15 °C for
18 h. 108 cells were incubated at 15 °C for 5 h (lanes 1-3); 108 cells were cultured for a
further 2 h at 15 °C before warming to 37 °C for 3 h
(lanes 4-6) and 108 cells were treated for
2 h at 15 °C with 100 µM zVAD-fmk before warming
to 37 °C for 3 h (T18: lanes 10-12). One sample of
108 freshly isolated neutrophils was treated with 100 µM zVAD-fmk at 15 °C for 20 h and then warmed to
37 °C for 3 h (lanes 7-9). Post-nuclear
supernatants (post-nuclear supernatants: lanes 1, 4, 7, and
10) were fractionated into membrane (M: lanes 2, 5, 8, and 11) and cytosol (C: lanes 3, 6, 9,
and 12) by ultracentrifugation, the membrane fractions being
re-homogenized to their original volume in buffer. The fractions were
immunoblotted with antibodies to Bax (upper panel) and
procaspase-3 (lower panel).
|
|
Bax insertion into mitochondria and the release of cytochrome
c in many experimental models is insensitive to zVAD-fmk
(28). In subcellular fractions from neutrophils cultured for 18 h
at 15 °C and treated with 100 µM zVAD-fmk for 2 h, before warming to 37 °C, Bax had translocated to the membrane
fraction (Fig. 8, upper panel, lane 11). Under
these conditions procaspase-3 was still present in the cytosol (Fig. 8,
lower panel, lane 12). However, when
freshly isolated neutrophils were treated with 100 µM
zVAD-fmk at 15 °C for 20 h prior to warming to 37 °C, Bax
remained in the cytosol fraction (Fig. 8, upper panel, lane
9) with procaspase-3 (Fig. 8, lower panel, lane 9). The
Bax present in the membrane fraction (Fig. 8, upper panel, lane
8) can be accounted for by the apoptotic cells (12%) present.
These results suggest that during incubation at 15 °C, caspase
activity may prepare Bax for translocation from the cytosol to
mitochondria and insertion into the mitochondrial membrane on warming
to 37 °C. Caspase-8, a potential candidate for the indirect
activation of Bax, can be detected in neutrophil cytosols. However,
procaspase-8 was not proteolytically cleaved during either incubations
at 15 °C or during the warming of 15 °C cultured neutrophils to
37 °C in the presence of zVAD-fmk (data not shown).
The Translocation of Bax to Neutrophil Mitochondria--
We
followed the translocation of Bax from the cytoplasm to mitochondria in
apoptotic neutrophils by confocal microscopy. Immunofluorescence staining of neutrophils with rabbit preimmune sera and Alexa dye-tagged secondary antibodies showed nuclear staining in freshly isolated neutrophils (Fig. 9A) and no
significant cytoplasmic staining. Anti-Bax polyclonal antibodies also
showed nuclear staining (Fig. 9B), but similar staining in
HeLa cells and Bax-deficient tumor cells suggested that this staining
was nonspecific (72). In fresh preparations of neutrophils the few
constitutively apoptotic neutrophils showed Bax staining of large
cytoplasmic structures (Fig. 9B, arrow). These
cytoplasmic structures were also stained with polyclonal antibodies to
ubiquinol cytochrome c oxidoreductase (complex III) that
co-localized with mtHSP70 staining (Fig. 9C), whose
expression was increased in many preparations of 15 °C cultured neutrophils. Significantly, staining of 15 °C cultured neutrophils with mtHSP70 (Fig. 9D) and Bax (Fig. 9E) showed
co-localization (yellow staining) in merged images (Fig. 9F)
of cytoplasmic structures that were present in cells that showed none
of the pyknotic nuclear morphology associated with neutrophil
apoptosis. Co-localization analysis, on single optical sections using
Leica TCS software, confirmed the subcellular co-localization of Bax
and mtHSP70 seen in the merged fluorescent micrographs (data not
shown). Bax appeared therefore to translocate to mitochondria at
15 °C, without triggering apoptosis. The binding of Bax to
mitochondria without insertion of its hydrophobic membrane-spanning
domain would be consistent with Bax being peripherally associated with
the mitochondrial membrane and redistributing to the cytosol fraction
during homogenization and washing of the membrane fraction (Fig. 8,
lane 3). After warming the 15 °C cultured neutrophils to
37 °C for 3 h, mtHSP70 staining (Fig. 9G) and Bax
staining (Fig. 9H) were co-localized in the merged
micrograph (Fig. 9I) with a small number of large, but discrete, cytoplasmic structures. Similar cytoplasmic structures have
been identified in HeLa cells treated with staurosporine to induce
apoptosis (72) and in cells overexpressing Bax (37, 38) as aggregates
of mitochondria. Not all mitochondria stained for Bax and some
Bax-stained structures did not stain with mtHSP70. There was therefore
a differential response by mitochondria to apoptotic signals and Bax
may also translocate to other membrane compartments. Neutrophils
cultured at 15 °C for 20 h then warmed to 37 °C for 3 h
showed no staining with rabbit preimmune sera (Fig. 9J).

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 9.
Intracellular localization of Bax by confocal
microscopy. Freshly isolated neutrophils showed no
significant cytoplasmic staining with rabbit preimmune serum and
anti-rabbit IgG-conjugated to AlexTM 568 (red)
(A), with polyclonal antibodies against Bax (B)
nor with monoclonal antibodies to the mitochondrial marker mtHSP70
detected with anti-mouse IgG-conjugated to AlexaTM 488 (green) (B). Nuclei were stained with TOPO-3TM
and the cells were analyzed by confocal microscopy and single optical
sections are shown. Apoptotic cells present in the freshly isolated
cells, however, showed Bax staining (red) of large
cytoplasmic structures (arrow in B) that
co-localized (yellow) with staining for both the
mitochondrial markers mtHSP70 (red) and complex III
(green) (C). After culture for 20 h at
15 °C (D-F) neutrophils showed staining for cytoplasmic
structures with mtHSP70 (D) and Bax (E) that
co-localized (yellow staining) in merged micrographs
(F). When the 15 °C cultured neutrophils were warmed to
37 °C for 3 h (G-I), they showed staining of several
discrete cytoplasmic structures. These were also stained for mtHSP70
(G) and Bax (H) and when the micrographs were
merged (I) the Bax and mtHSP70 staining was mainly
co-localized, although there were some structures that stained for only
one or another of the antibodies. A control 15 °C culture was warmed
to 37 °C for 3 h and stained with rabbit preimmune
(J). Freshly isolated neutrophils were treated for 20 h
with 100 µM zVAD-fmk and then warmed to 37 °C for
3 h. The micrograph (K) shows the merged staining for
Bax and mtHSP70. Neutrophils were cultured at 15 °C for 18 h
and then treated at 15 °C for 2 h with 100 µM
zVAD-fmk before warming to 37 °C for 3 h. The micrograph
(L) again shows the merged staining for Bax and mtHSP70. The
bar represents 5 µM.
|
|
After culture of neutrophils at 15 °C for 20 h with zVAD-fmk
and warming to 37 °C for 3 h there was no significant Bax
staining of neutrophil mitochondria that showed non-apoptotic nuclear
morphology (Fig. 9K). This was consistent with the
immunoblotting data (Fig. 8, upper panel, lanes 7-9) that
showed no insertion of Bax into mitochondria. However, neutrophils
cultured at 15 °C for 18 h, then treated for 2 h with
zVAD-fmk before warming to 37 °C for 3 h, did show significant
Bax and mtHSP70 staining (Fig. 9L). This was consistent with
immunoblotting data that showed that Bax had translocated to the
membrane fraction (Fig. 8, upper panel, lanes
10-12). While the nuclear morphology was significantly different from the nuclei of freshly isolated neutrophils under these conditions, the pyknotic nuclear morphology characteristic of apoptotic neutrophils was not detected and there was no fragmentation of DNA under these conditions (see Fig. 2, A-C).
 |
DISCUSSION |
We have shown for the first time that culturing neutrophils at
15 °C reversibly arrests the induction of apoptosis, with subsequent warming to 37 °C triggering a burst of synchronous apoptosis. The
molecular consequences of temperature reduction on cells are poorly
understood. However, between 10 and 20 °C there is a reduction in
membrane lipid fluidity, a decrease in the rate of protein translation,
and an inhibition of vesicular trafficking and neutrophil respiratory
burst activity (67, 50, 51). Our results suggest that the arrest of
apoptosis in neutrophils cultured at 15 °C may be due to the failure
of the proapoptotic protein Bax to undergo the conformational changes
necessary for it to insert into mitochondria. Once in the membrane Bax
triggers the release of cytochrome c and the subsequent
activation of caspase-3 that induces the execution phase of neutrophil apoptosis.
Bax is a soluble protein located in the cytoplasm of freshly isolated
neutrophils (10-12). Our immunofluorescence studies on Bax
localization in neutrophils cultured at 15 °C have shown that in
addition to its cytoplasmic localization, Bax was also associated with
mitochondria that showed signs of aggregation; both observations reported for many cell lines cultured at 37 °C (73). However, in
neutrophils cultured at 15 °C Bax failed to undergo the
conformational changes necessary for insertion of its C-terminal
membrane-spanning domain into mitochondria (33). Bax was readily washed
from membranes isolated from neutrophils cultured at 15 °C
suggesting a peripheral association with the membrane fraction. The
N-terminal region of the Bax molecule may bind to and mask its
C-terminal domain in the cytoplasm and the removal of the N-terminal
domain leads to an autoactivation and constitutive insertion of the
mutant protein into mitochondria (72). The cytoplasmic components that normally facilitate this unmasking of the C-terminal membrane-spanning domain and the conformational changes to neutrophil Bax are unknown. However, in HeLa cells, for example, the proapoptotic protein Bid, can
induce the insertion of Bax into membranes (22, 72) and may be one of a
number of cytoplasmic factors that play a role in the release of
cytochrome c from mitochondria (29).
In many models of apoptosis the insertion of Bax into mitochondria and
the subsequent release of cytochrome c are not inhibited by
the pan-caspase inhibitor zVAD-fmk, while proteolytic cleavage of
procaspase-3 is inhibited (28). Treatment of neutrophils, cultured at
15 °C for 18 h, with zVAD-fmk prior to triggering apoptosis by
warming to 37 °C, also failed to inhibit Bax translocation to
neutrophil membranes under conditions where procaspase-3 was not
proteolytically cleaved, consistent with other models of apoptosis. However, when freshly isolated neutrophils were treated with zVAD-fmk at the beginning of the culture period at 15 °C, Bax failed to insert into mitochondria when the cells were warmed to 37 °C. Assuming the fidelity of zVAD-fmk for its caspase targets, these experiments suggested that caspase-mediated events were necessary for
Bax insertion (74) but were not in themselves a sufficient trigger for
the induction of Bax insertion into mitochondria at 15 °C. Whatever
the role the caspases play in preparing Bax, or in activating a
putative effector protein necessary for the activation of Bax binding
and insertion once the neutrophils are warmed to 37 °C, we saw no
evidence that Bax was proteolytically cleaved at 15 °C. Activation
of an effector protein and Bax binding at 15 °C would provide an
explanation for the synchronization of apoptosis we observe on warming
the cells to 37 °C after culture at 15 °C. Direct proteolytic
cleavage of p21 Bax does not appear to be involved in the translocation
of Bax to mitochondria (70, 71). However, caspases have been shown to
activate the calcium-activated cysteine protease, calpain, that cleaves
p21 Bax to p18 Bax at the mitochondrial membrane (70, 71). While this
proteolytic processing by calpain augments the homodimerization of Bax
and the release of cytochrome c it is a relatively late
apoptotic event concomitant temporally with the cleavage of many other
caspase-3 substrates and with DNA fragmentation (75, 76).
The conformational changes necessary for neutrophil Bax to insert into
the mitochondrial membrane were not only inhibited by low temperature,
but also by clamping neutrophils at an acidic pHi during
warming to 37 °C, a treatment that was dominant over the effect of
temperature reduction. In FL5.12 cells and D1 thymocyte cell lines
transient increases in cytoplasmic pHi have been correlated
with pH-dependent conformational change in Bax, an effect
that is also inhibited by acid pH (39, 64, 73). This observation may
provide an explanation for the inhibition of neutrophil apoptosis
observed at inflammatory foci where an acid environment has developed
(59). Our data are also consistent with the observation that tumor
necrosis factor/cycloheximide-induced cytochrome c release
is inhibited by zVAD-fmk (30) and that caspase-8 may trigger the
release of cytochrome c (77). However, our preliminary data
(not shown) have suggested that procaspase-8, like procaspase-3 is not
proteolytically cleaved at 15 or at 37 °C in the presence of
zVAD-fmk, under conditions where Bax insertion occurs.
How cytochrome c is translocated across the outer membrane
of mitochondria is not known (41, 68, 78, 79). Bax insertion may affect
membrane channels by inducing permeability changes that result in the
release of cytochrome c (78, 80-82). Many cells that obtain
their ATP by oxidative phosphorylation can still release cytochrome
c from mitochondria at low temperature (30, 81). It was
possible that extended culture at low temperature would lead to
collapse of the inner mitochondrial membrane potential ( m) and trigger the opening of the mitochondrial
permeability transition pore in neutrophils, an event that correlates
with the insertion of Bax and the induction of apoptosis (27, 41, 68).
In granulocytes, however, ATP is obtained predominantly by glycolysis
and this may allow their mitochondria to use pyruvate to maintain their
 m at low temperature. Apoptosis triggered by warming
15 °C cultured neutrophils to 37 °C was not inhibited by
preincubation with 50 µM bongkrekic acid (data not
shown), an inhibitor that blocks the permeability transition pore (37, 77). This experiment suggested that the collapse of the membrane potential might be an event triggered downstream of caspase-3 activation (28).
The Bax-dependent release of cytochrome c from
mitochondria in 15 °C cultured neutrophils, treated with zVAD-fmk
just before warming to 37 °C to inhibit caspase-3, triggered the
activation of apoptosis inducing activities that led to the arrest of
both secretion and phagocytosis (57). The externalization of
phosphatidylserine on the cell surface was also induced and this may
trigger recognition and phagocytosis of granulocytes by macrophages
(55). We have established that mitochondria play a role in triggering
neutrophil apoptosis. Our 15 °C cytosols will now enable us to
investigate not only the zVAD-fmk sensitive activity that is required
for Bax insertion into mitochondria, but also the zVAD-fmk insensitive activities triggered during cytochrome c release, that lead
to the apoptotic changes associated with the neutrophil plasma
membrane. Finally, the differential response of granulocytes and
proliferating cells to temperature reduction suggests that therapeutic
targets specific for triggering of neutrophil apoptosis may possibly be identified in this clinically relevant cellular model of apoptosis.
 |
ACKNOWLEDGEMENTS |
We thank Ian Dransfield for help with flow
cytometry and Linda Sharp for help with confocal microscopy. Said
Aoufuchi, Simon Brown, and David Apps are thanked for gifts of
antibodies. We are grateful to Tim Allsopp, David Apps, Ian
Dransfield,Jonathan Lamb, Mary McElroy, and Deborah Pryde for critical
reading of the manuscript and discussions during the course of this work.
 |
FOOTNOTES |
*
This work is supported by Program Grant G9016491 from the
Medical Research Council, United Kingdom.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Respiratory Medicine
Unit, Dept. of Medicine (RIE), Rayne Laboratory, University of
Edinburgh Medical School, Teviot Place, Edinburgh, EH8 9AG. Scotland,
UK. Tel.: 44-131-650-6949; Fax: 44-131-650-4384; E-mail: j.pryde@ed.ac.uk.
§
Supported by University of Edinburgh Faculty of Medicine, Vans
Dunlop, and Shaw McFie Lang Postgraduate Research Scholarships.
Published, JBC Papers in Press, July 13, 2000, DOI 10.1074/jbc.M001008200
2
J. Pryde unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
zVAD-fmk, benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone;
Apaf-1, apoptosis
protease activating factor;
PARP, poly(ADP-ribose) polymerase;
FITC, fluorescein isothiocyanate;
PAGE, polyacrylamide gel electrophoresis;
Pipes, 1,4-piperazinediethane sulfonic acid;
Mes, 2-(N-morpholino)ethanesulfonic acid;
TUNEL, terminal
deoxynucleotydyl transferase (tdt)-mediated dUTP-FITC nick end
labeling;
BSA, bovine serum albumin;
mtHSP, mitochondrial heat shock
protein 70;
SNARF-1, seminaphthorhodafluor-1.
 |
REFERENCES |
| 1.
|
Wyllie, A. H.,
Kerr, J. F. R.,
and Currie, A. R.
(1980)
Int. Rev. Cytol.
68,
251-306
|
| 2.
|
Savill, J. S.,
Wyllie, A. H.,
Henson, J. E.,
Walport, M. J.,
Henson, P. M.,
and Haslett, C.
(1989)
J. Clin. Invest.
83,
865-875
|
| 3.
|
Whyte, M. K. B.,
Meagher, L. C.,
MacDermot, J.,
and Haslett, C.
(1993)
J. Immunol.
150,
5124-5134
|
| 4.
|
Savill, J.,
Dransfield, I.,
Hogg, N.,
and Haslett, C.
(1990)
Nature
343,
170-173
|
| 5.
|
Savill, J.,
Hogg, N.,
Ren, Y.,
and Haslett, C.
(1992)
J. Clin. Invest.
90,
1513-1522
|
| 6.
|
Meagher, L. C.,
Savill, J. S.,
Baker, A.,
Fuller, R. W.,
and Haslett, C.
(1992)
J. Leukocyte Biol.
52,
269-273
|
| 7.
|
Lee, A.,
Whyte, M. K. B.,
and Haslett, C.
(1993)
J. Leukocyte Biol.
54,
283-288
|
| 8.
|
Hannah, S.,
Mecklenburgh, K.,
Rahman, I.,
Bellingan, G. J.,
Greening, A.,
Haslett, C.,
and Chilvers, E. R.
(1995)
FEBS Lett.
372,
233-237
|
| 9.
|
Weinmann, P.,
Gaehtgens, P.,
and Walzog, B.
(1999)
Blood
93,
3106-3115
|
| 10.
|
Moulding, D. A.,
Quayle, J. A.,
Hart, C. A.,
and Edwards, S. W.
(1998)
Blood
92,
2495-2502
|
| 11.
|
Lagasse, E.,
and Weissman, I. L.
(1994)
J. Exp. Med.
179,
1047-1052
|
| 12.
|
Ohta, H.,
Yatomi, Y.,
Sweeney, E. A.,
Hakomori, S.,
and Igarashi, Y.
(1994)
FEBS Lett.
355,
267-270
|
| 13.
|
Liles, W. C.,
Kiener, P. A.,
Ledbetter, J. A.,
Aruffo, A.,
and Klebanoff, S. J.
(1996)
J. Exp. Med.
184,
429-440
|
| 14.
|
Matsumoto, K.,
Schleimer, R. P.,
Saito, H.,
Iikura, Y.,
and Bochner, B. S.
(1995)
Blood
86,
1437-1443
|
| 15.
|
Frasch, S. C.,
Nick, J. A.,
Fadok, V. A.,
Bratton, D. L.,
Worthen, G. S.,
and Henson, P. M.
(1998)
J. Biol. Chem.
273,
8389-8397
|
| 16.
|
Ward, C.,
Chilvers, E. R.,
Lawson, M. F.,
Pryde, J. G.,
Fujihara, S.,
Farrow, S. N.,
Haslett, C.,
and Rossi, A. G.
(1999)
J. Biol. Chem.
274,
4309-4318
|
| 17.
|
Sanghavi, D. M.,
Thelen, M.,
Thornberry, N. A.,
Casciola-Rosen, L.,
and Rosen, A.
(1998)
FEBS Lett.
422,
179-184
|
| 18.
|
Korsmeyer, S. J.
(1995)
Trends Genet.
11,
101-105
|
| 19.
|
Yamashita, K.,
Takahashi, A.,
Kobayashi, S.,
Hirata, H.,
Mesner, P. W.,
Kaufmann, S. H.,
Yonehara, S.,
Yamamoto, K.,
Uchiyama, T.,
and Sasada, M.
(1999)
Blood
93,
674-685
|
| 20.
|
Yuan, J.,
and Horvitz, H. R.
(1990)
Dev. Biol.
138,
33-41
|
| 21.
|
Stennicke, H. R.,
Jürgensmeier, J. M.,
Shin, H.,
Deveraux, Q.,
Wolf, B. B.,
Yang, X.,
Zhou, Q.,
Ellerby, H. M.,
Ellerby, L. M.,
Bredesen, D.,
Green, D. R.,
Reed, J. C.,
Froelich, C. J.,
and Salvesen, G. S.
(1998)
J. Biol. Chem.
273,
27084-27090
|
| 22.
|
Kuwana, T.,
Smith, J. J.,
Muzio, M.,
Dixit, V.,
Newmeyer, D. D.,
and Kornbluth, S.
(1998)
J. Biol. Chem.
273,
16589-16594
|
| 23.
|
Susin, S. A.,
Zamzami, N.,
Castedo, M.,
Hirsch, T.,
Marchetti, P.,
Macho, A.,
Daugas, E.,
Geuskens, M.,
and Kroemer, G.
(1996)
J. Exp. Med.
184,
1331-1341
|
| 24.
|
Li, F.,
Srinivasan, A.,
Wang, Y.,
Armstrong, R. C.,
Tomaselli, K. J.,
and Fritz, L. C.
(1997)
J. Biol. Chem.
272,
30299-30305
|
| 25.
|
Kluck, R. M.,
Martin, S. J.,
Hoffman, B. M.,
Zhou, J. S.,
Green, D. R.,
and Newmeyer, D. D.
(1997)
EMBO J.
16,
4639-4649
|
| 26.
|
Zou, H.,
Henzel, W. J.,
Liu, X.,
Lutschg, A.,
and Wang, X.
(1997)
Cell
90,
405-413
|
| 27.
|
Kluck, R. M.,
Bossy-Wetzel, E.,
Green, D. R.,
and Newmeyer, D. D.
(1997)
Science
275,
1132-1136
|
| 28.
|
Bossy-Wetzel, E.,
Newmeyer, D. D.,
and Green, D. R.
(1998)
EMBO J.
17,
37-49
|
| 29.
|
Bossy-Wetzel, E.,
and Green, D. R.
(1999)
J. Biol. Chem.
274,
17484-17490
|
| 30.
|
Goldstein, J. C.,
Waterhouse, N. J.,
Juin, P.,
Evan, G. I.,
and Green, D. R.
(2000)
Nat. Cell Biol.
2,
156-162
|
| 31.
|
Oltvai, Z. N.,
Milliman, C. L.,
and Korsmeyer, S. J.
(1993)
Cell
74,
609-619
|
| 32.
|
Wolter, K. G.,
Hsu, Y-T.,
Smith, C. L.,
Nechushtan, A.,
Xi, X-G.,
and Youle, R. J.
(1997)
J. Cell Biol.
139,
1281-1292
|
| 33.
|
Nechushtan, A.,
Smith, C. L.,
Hsu, Y-T.,
and Youle, R. J.
(1999)
EMBO J.
18,
2330-2341
|
| 34.
|
Hsu, Y-T.,
Wolter, K. G.,
and Youle, R. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3668-3672
|
| 35.
|
Hsu, Y-T.,
and Youle, R. J.
(1997)
J. Biol. Chem.
272,
13829-13834
|
| 36.
|
Jürgensmeier, J. M.,
Xie, Z.,
Deveraux, Q.,
Ellerby, L.,
Bredesen, D.,
and Reed, J. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4997-5002
|
| 37.
|
Eskes, R.,
Antonsson, B.,
Osen-Sand, A.,
Montessuit, S.,
Richter, C.,
Sadoul, R.,
Mazzei, G.,
Nichols, A.,
and Martinou, J-C.
(1998)
J. Cell Biol.
143,
217-224
|
| 38.
|
Narita, M.,
Shimizu, S.,
Ito, T.,
Chittenden, T.,
Lutz, R. J.,
Matsuda, H.,
and Tsujimoto, Y.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14681-14686
|
| 39.
|
Gross, A.,
Jockel, J.,
Wei, M. C.,
and Korsmeyer, S. J.
(1998)
EMBO J.
17,
3878-3885
|
| 40.
|
Rosse, T.,
Olivier, R.,
Monney, L.,
Rager, M.,
Conus, S.,
Fellay, I.,
Jansen, B.,
and Borner, C.
(1998)
Nature
391,
496-499
|
| 41.
|
Shimizu, S.,
Narita, M.,
and Tsujimoto, Y.
(1999)
Nature
399,
483-487
|
| 42.
|
Li, P.,
Nijhawan, D.,
Budihardjo, I.,
Srinivasula, S. M.,
Ahmad, M.,
Alnemri, E. S.,
and Wang, X.
(1997)
Cell
91,
479-489
|
| 43.
|
Slee, E. A.,
Harte, M. T.,
Kluck, R. M.,
Wolf, B. B.,
Casiano, C. A.,
Newmeyer, D. D.,
Wang, H-G.,
Reed, J. C.,
Nicholson, D. W.,
Alnemri, E. S.,
Green, D. R.,
and Martin, S. J.
(1999)
J. Cell Biol.
144,
281-292
|
| 44.
|
Haslett, C.,
Guthrie, L. A.,
Kopaniak, M. M.,
Johnston, R. B.,
and Henson, P. M.
(1985)
Am. J. Pathol.
119,
101-110
|
| 45.
|
Eldadah, B. A.,
Yakovlev, A. G.,
and Faden, A. I.
(1996)
Nucleic Acids Res.
24,
4092-4093
|
| 46.
|
Pryde, J. G.
(1994)
J. Cell Sci.
107,
3425-3436
|
| 47.
|
Nicholson, D. W.,
and McMurray, W. C.
(1984)
Can. J. Biochem. Cell Biol.
62,
1205-1216
|
| 48.
|
Newmeyer, D. D.,
Farschon, D. M.,
and Reed, J. C.
(1994)
Cell
79,
353-364
|
| 49.
|
Earnshaw, W. C.
(1995)
Curr. Opin. Cell Biol.
7,
337-343
|
| 50.
|
Tartakoff, A. M.
(1986)
EMBO J.
5,
1477-1482
|
| 51.
|
Manara, F. S.,
and Schneider, D. L.
(1985)
Biochem. Biophys. Res. Commun.
132,
696-701
|
| 52.
|
Shimura, M.,
Ishizaka, Y.,
Yuo, A.,
Hatake, K.,
Oshima, M.,
Sasaki, T.,
and Takaku, F.
(1997)
FEBS Lett.
417,
379-384
|
| 53.
|
Tang, D.,
Lahti, J. M.,
Grenet, J.,
and Kidd, V. J.
(1999)
J. Biol. Chem.
274,
7245-7252
|
| 54.
|
Gregory, C. D.,
and Milner, A. E.
(1994)
Int. J. Cancer.
57,
419-426
|
| 55.
|
Martin, S. J.,
Finucane, D. M.,
Amarante-Mendes, G. P.,
O'Brien, G. A.,
and Green, D. R.
(1996)
J. Biol. Chem.
271,
28753-28756
|
| 56.
|
Vanags, D. M.,
Pörn-Ares, M. I.,
Coppola, S.,
Burgess, D. H.,
and Orrenius, S.
(1996)
J. Biol. Chem.
271,
31075-31085
|
| 57.
|
Zhuang, J.,
Ren, Y.,
Snowden, R. T.,
Zhu, H.,
Gogvadze, V.,
Savill, J. S.,
and Cohen, G. M.
(1998)
J. Biol. Chem.
273,
15628-15632
|
| 58.
|
Jacobson, M. D.,
Weil, M.,
and Raff, M. C.
(1997)
Cell
88,
347-354
|
| 59.
|
Trevani, A. S.,
Andonegui, G.,
Giordano, M.,
López, D. H.,
Gamberale, R.,
Minucci, F.,
and Geffner, J. R.
(1999)
J. Immunol.
162,
4849-4857
|
| 60.
|
Li, J.,
and Eastman, A.
(1995)
J. Biol. Chem.
270,
3203-3211
|
| 61.
|
Furlong, I. J.,
Ascaso, R.,
Rivas, A. L.,
and Collins, M. K.
(1997)
J. Cell Sci.
110,
653-661
|
| 62.
|
Musgrove, E. A.,
and Hedley, D. W.
(1990)
Methods Cell Biol.
33,
59-69
|
| 63.
|
Benson, R. S. P.,
Dive, C.,
and Watson, A. J. M.
(1999)
J. Cell Sci.
112,
1755-1760
|
| 64.
|
Khaled, A. R.,
Kim, K.,
Hofmeister, R.,
Muegge, K.,
and Durum, S. K.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14476-14481
|
| 65.
|
Woo, M.,
Hakem, R.,
Soengas, M. S.,
Duncan, G. S.,
Shahinian, A.,
Kägi, D.,
Hakem, A.,
McCurrach, M.,
Khoo, W.,
Kaufman, S. A.,
Senaldi, G.,
Howard, T.,
Lowe, S. W.,
and Mak, T. W.
(1998)
Genes Dev.
12,
806-819
|
| 66.
|
Kumamoto, J.,
Raison, J. K.,
and Lyons, J. M.
(1971)
J. Theor. Biol.
31,
47-51
|
| 67.
|
Liu, G.,
Hinch, B.,
Davatol-Hag, H.,
Lu, Y.,
Powers, M.,
and Beavis, A. D.
(1996)
J. Biol. Chem.
271,
19717-19723
|
| 68.
|
Green, D. R.,
and Reed, J. C.
(1998)
Science
281,
1309-1312
|
| 69.
|
Schlesinger, P. H.,
Gross, A.,
Yin, X-M.,
Yamamoto, K.,
Saito, M.,
Waksman, G.,
and Korsmeyer, S. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11357-11362
|
| 70.
|
Wood, D. E.,
Thomas, A.,
Devi, L. A.,
Berman, Y.,
Beavis, R. C.,
Reed, J. C.,
and Newcomb, E. W.
(1998)
Oncogene
17,
1069-1078
|
| 71.
|
Kirsch, D. G.,
Doseff, A.,
Chau, B. N.,
Lim, D-S.,
De Souza-Pinto, N. C.,
Hansford, R.,
Kastan, M. B.,
Lazebnik, Y. A.,
and Hardwick, J. M.
(1999)
J. Biol. Chem.
274,
21155-21161
|
| 72.
|
Desagher, S.,
Osen-Sand, A.,
Nichols, A.,
Eskes, R.,
Montessuit, S.,
Lauper, S.,
Maundrell, K.,
Antonsson, B.,
and Martinou, J-C.
(1999)
J. Cell Biol.
144,
891-901
|
| 73.
|
Goping, I. S.,
Gross, A.,
Lavoie, J. N.,
Nguyen, M.,
Jemmerson, R.,
Roth, K.,
Korsmeyer, S. J.,
and Shore, G. C.
(1998)
J. Cell Biol.
143,
207-215
|
| 74.
|
Murphy, K. M.,
Streips, U. N.,
and Lock, R. B.
(1999)
Oncogene
18,
5991-5999
|
| 75.
|
Wood, D. E.,
and Newcomb, E. W.
(1999)
J. Biol. Chem.
274,
8309-8315
|
| 76.
|
Wood, D. E.,
and Newcomb, E. W.
(2000)
Exp. Cell Res.
256,
375-382
|
| 77.
|
Srinivasan, A.,
Li, F.,
Wong, A.,
Kodandapani, L.,
Smidt, R.,
Krebs, J. F.,
Fritz, L. C.,
Wu, J. C.,
and Tomaselli, K. J.
(1998)
J. Biol. Chem.
273,
4523-4529
|
| 78.
|
Heidin, M. G.,
Chandel, N. S.,
Schumacker, P. T.,
and Thompson, C. B.
(1999)
Mol. Cell
3,
159-167
|
| 79.
|
Marzo, I.,
Brenner, C.,
Zamzami, N.,
Susin, S. A.,
Beutner, G.,
Brdiczka, D.,
Remy, R.,
Xie, Z. H.,
Reed, J. C.,
and Kroemer, G.
(1998)
J. Exp. Med.
187,
1261-1271
|
| 80.
|
Marchetti, P.,
Castedo, M.,
Susin, S. A.,
Zamzami, N.,
Hirsch, T.,
Macho, A.,
Haeffner, A.,
Hirsch, F.,
Geuskens, M.,
and Kroemer, G.
(1996)
J. Exp. Med.
184,
1155-1160
|
| 81.
|
Heiskanen, K. M.,
Bhat, M. B.,
Wang, H. W.,
Ma, J.,
and Nieminen, A. L.
(1999)
J. Biol. Chem.
274,
5654-5658
|
| 82.
|
Basanez, G.,
Nechushtan, A.,
Drozhinin, O.,
Chanturitya, A.,
Choe, E.,
Tutt, S.,
Wood, K. A.,
Hsu, Y-T.,
Zimmerberg, J.,
and Youle, R. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
5492-5497
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Q. Remijsen, T. Vanden Berghe, E. Parthoens, B. Asselbergh, P. Vandenabeele, and J. Willems
Inhibition of spontaneous neutrophil apoptosis by parabutoporin acts independently of NADPH oxidase inhibition but by lipid raft-dependent stimulation of Akt
J. Leukoc. Biol.,
March 1, 2009;
85(3):
497 - 507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jitkaew, E. Witasp, S. Zhang, V. E. Kagan, and B. Fadeel
Induction of caspase- and reactive oxygen species-independent phosphatidylserine externalization in primary human neutrophils: role in macrophage recognition and engulfment
J. Leukoc. Biol.,
March 1, 2009;
85(3):
427 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pederzoli, C. Kantari, V. Gausson, S. Moriceau, and V. Witko-Sarsat
Proteinase-3 Induces Procaspase-3 Activation in the Absence of Apoptosis: Potential Role of this Compartmentalized Activation of Membrane-Associated Procaspase-3 in Neutrophils
J. Immunol.,
May 15, 2005;
174(10):
6381 - 6390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Nusbaum, C. Laine, M. Bouaouina, S. Seveau, E. M. Cramer, J. M. Masse, P. Lesavre, and L. Halbwachs-Mecarelli
Distinct Signaling Pathways Are Involved in Leukosialin (CD43) Down-regulation, Membrane Blebbing, and Phospholipid Scrambling during Neutrophil Apoptosis
J. Biol. Chem.,
February 18, 2005;
280(7):
5843 - 5853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Scheel-Toellner, K. Wang, R. Craddock, P. R. Webb, H. M. McGettrick, L. K. Assi, N. Parkes, L. E. Clough, E. Gulbins, M. Salmon, et al.
Reactive oxygen species limit neutrophil life span by activating death receptor signaling
Blood,
October 15, 2004;
104(8):
2557 - 2564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Maianski, D. Roos, and T. W. Kuijpers
Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis Are Inhibited by Granulocyte Colony-Stimulating Factor
J. Immunol.,
June 1, 2004;
172(11):
7024 - 7030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Gardai, D. A. Hildeman, S. K. Frankel, B. B. Whitlock, S. C. Frasch, N. Borregaard, P. Marrack, D. L. Bratton, and P. M. Henson
xPhosphorylation of Bax Ser184 by Akt Regulates Its Activity and Apoptosis in Neutrophils
J. Biol. Chem.,
May 14, 2004;
279(20):
21085 - 21095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Zhang, J. Hirahashi, X. Cullere, and T. N. Mayadas
Elucidation of Molecular Events Leading to Neutrophil Apoptosis following Phagocytosis: CROSS-TALK BETWEEN CASPASE 8, REACTIVE OXYGEN SPECIES, AND MAPK/ERK ACTIVATION
J. Biol. Chem.,
August 1, 2003;
278(31):
28443 - 28454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wang, D. Scheel-Toellner, S. H. Wong, R. Craddock, J. Caamano, A. N. Akbar, M. Salmon, and J. M. Lord
Inhibition of Neutrophil Apoptosis by Type 1 IFN Depends on Cross-Talk Between Phosphoinositol 3-Kinase, Protein Kinase C-{delta}, and NF-{kappa}B Signaling Pathways
J. Immunol.,
July 15, 2003;
171(2):
1035 - 1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fossati, D. A. Moulding, D. G. Spiller, R. J. Moots, M. R. H. White, and S. W. Edwards
The Mitochondrial Network of Human Neutrophils: Role in Chemotaxis, Phagocytosis, Respiratory Burst Activation, and Commitment to Apoptosis
J. Immunol.,
February 15, 2003;
170(4):
1964 - 1972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. McShane, J.C. Davies, M.G. Davies, A. Bush, D.M. Geddes, and E.W.F.W. Alton
Airway surface pH in subjects with cystic fibrosis
Eur. Respir. J.,
January 1, 2003;
21(1):
37 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N F Fanning, B J Manning, J Buckley, and H P Redmond
Iodinated contrast media induce neutrophil apoptosis through a mitochondrial and caspase mediated pathway
Br. J. Radiol.,
November 1, 2002;
75(899):
861 - 873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Coakley, C. Taggart, N. G. McElvaney, and S. J. O'Neill
Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis
Blood,
October 16, 2002;
100(9):
3383 - 3391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. I. Mecklenburgh, S. R. Walmsley, A. S. Cowburn, M. Wiesener, B. J. Reed, P. D. Upton, J. Deighton, A. P. Greening, and E. R. Chilvers
Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis
Blood,
September 26, 2002;
100(8):
3008 - 3016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Cowburn, K. A. Cadwallader, B. J. Reed, N. Farahi, and E. R. Chilvers
Role of PI3-kinase-dependent Bad phosphorylation and altered transcription in cytokine-mediated neutrophil survival
Blood,
September 18, 2002;
100(7):
2607 - 2616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Lavastre, M. Pelletier, R. Saller, K. Hostanska, and D. Girard
Mechanisms Involved in Spontaneous and Viscum album Agglutinin-I-Induced Human Neutrophil Apoptosis: Viscum album Agglutinin-I Accelerates the Loss of Antiapoptotic Mcl-1 Expression and the Degradation of Cytoskeletal Paxillin and Vimentin Proteins Via Caspases
J. Immunol.,
February 1, 2002;
168(3):
1419 - 1427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dewson, G. M. Cohen, and A. J. Wardlaw
Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophils
Blood,
October 1, 2001;
98(7):
2239 - 2247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Martin, I. Dransfield, C. Haslett, and A. G. Rossi
Cyclic AMP Regulation of Neutrophil Apoptosis Occurs via a Novel Protein Kinase A-independent Signaling Pathway
J. Biol. Chem.,
November 21, 2001;
276(48):
45041 - 45050.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|